Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 3 institutions in 2 countries.
Begoña Febrer-SendraInfectious and Tropical Diseases Research Group (e-INTRO), Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, 37008 Salamanca, Spain.ORCID 0000-0001-5940-6572
Pedro Fernández-SotoInfectious and Tropical Diseases Research Group (e-INTRO), Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, 37008 Salamanca, Spain.ORCID 0000-0002-4089-4307
Beatriz Crego-VicenteInfectious and Tropical Diseases Research Group (e-INTRO), Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, 37008 Salamanca, Spain.
Juan García-Bernalt DiegoInfectious and Tropical Diseases Research Group (e-INTRO), Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, 37008 Salamanca, Spain.ORCID 0000-0001-6947-6806
Thuy-Huong Ta-TangMalaria and Neglected Tropical Diseases Laboratory, National Centre of Tropical Medicine, CIBERINFEC, Institute of Health Carlos III, 28029 Madrid, Spain.
Pedro BerzosaMalaria and Neglected Tropical Diseases Laboratory, National Centre of Tropical Medicine, CIBERINFEC, Institute of Health Carlos III, 28029 Madrid, Spain.
Rufino NguemaNational Control Programme of Onchocerciasis and Other Filariasis, Ministry of Health, Malabo, Equatorial Guinea.
Policarpo NcogoNational Control Programme of Onchocerciasis and Other Filariasis, Ministry of Health, Malabo, Equatorial Guinea.
María Romay-BarjaMalaria and Neglected Tropical Diseases Laboratory, National Centre of Tropical Medicine, CIBERINFEC, Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-0177-6885
Zaida HerradorMalaria and Neglected Tropical Diseases Laboratory, National Centre of Tropical Medicine, CIBERINFEC, Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-6508-3818
Agustín BenitoMalaria and Neglected Tropical Diseases Laboratory, National Centre of Tropical Medicine, CIBERINFEC, Institute of Health Carlos III, 28029 Madrid, Spain.
Antonio MuroInfectious and Tropical Diseases Research Group (e-INTRO), Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, 37008 Salamanca, Spain.ORCID 0000-0003-0244-4740
Instituto de Salud Carlos III · ESUniversidad de Salamanca · ESNational University of Equatorial Guinea · GQ
Funding
Instituto de Salud Carlos III FCSAI-ISCIIIInstituto de Salud Carlos III PI19/01727Instituto de Salud Carlos III RD16/0027/0000Instituto de Salud Carlos III RD16/0027/0018Instituto de Salud Carlos III Sara Borrell CD17CIII/00018Junta de Castilla y León BDNS (Identif.): 422058Junta de Castilla y León BDNS (Identif.): 487971University of Salamanca Predoctoral Felowship program cofinancing by Santander Bank
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Colorimetric and Real-Time Loop-Mediated Isothermal Amplification (LAMP) for Detection of · full record | OpenQuestion